Financial Instruments (Tables)

12 Months Ended

Jan. 01, 2022

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance

A summary of the company’s interest rate swaps is as follows (in thousands):

		Twelve Months Ended
	Location	Jan 1, 2022		Jan 2, 2021
Fair value	Other assets	$	3,645	$	—
Fair value	Accrued expenses	$	1,171	$	14,075
Fair value	Other non-current liabilities	$	20,464	$	37,018
Amount of gain/(loss) recognized in other comprehensive income	Other comprehensive income	$	14,634	$	(43,317)
Gain/(loss) reclassified from accumulated other comprehensive income (effective portion)	Interest expense	$	(18,469)	$	(15,514)